Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.53 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.53 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.53 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | PRNP | P04156 | 1/20 | 0.43 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29811281 | 1.00 | ALDH1A1 (0.73) | ALDH1A1KMT2AMAPTEHMT2EHMT1 | |
| SCHEMBL30308346 | 0.98 | ALDH1A1 (0.71) | ALDH1A1KMT2AMAPTEHMT2EHMT1 | |
| Succinic Acid SCHEMBL28529727 | 0.98 | ALDH1A1 (0.71) | ALDH1A1KMT2AMAPTEHMT2EHMT1 | |
| SCHEMBL123215 | 0.92 | ALDH1A1 (0.62) | ALDH1A1KMT2AMAPTEHMT2EHMT1 | |
| Hydrochloric Acid SCHEMBL16539188 | 0.91 | ALDH1A1 (0.60) | ALDH1A1KMT2AMAPTEHMT2EHMT1 | |
| SCHEMBL3101921 | 0.91 | ALDH1A1 (0.60) | ALDH1A1KMT2AMAPTEHMT2EHMT1 | |
| SCHEMBL3736785 | 0.90 | ALDH1A1 (0.69) | ALDH1A1KMT2AMAPTEHMT2EHMT1 | |
| SCHEMBL17256326 | 0.89 | ALDH1A1 (0.59) | ALDH1A1KMT2AMAPTEHMT2EHMT1 | |
| SCHEMBL31005435 | 0.89 | ALDH1A1 (0.59) | ALDH1A1KMT2AMAPTEHMT2EHMT1 | |
| SCHEMBL14921878 | 0.89 | ALDH1A1 (0.59) | ALDH1A1KMT2AMAPTEHMT2EHMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4193 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122006676-A | Nanoparticle for enriching low-abundance protein in blood plasma, preparation method thereof and application thereof in early cancer screening | 中国科学院长春应用化学研究所 | 2026-05-12 | — | — | CN | claimed |
| EP-3765188-B1 | SURFACE FUNCTIONALISED MATERIALS FOR SAMPLING BIOLOGICAL MOLECULES | JONES PAUL ANTONIO (GB) | 2025-04-16 | — | — | EP | claimed |
| CN-119716073-A | Nanopore polypeptide sequencing method based on interaction of host and guest | 中国科学院化学研究所 | 2025-03-28 | — | — | CN | claimed |
| EP-3368028-B1 | DENDERIMER COMPOSITIONS AND USE IN TREATMENT OF NECROTIZING ENTEROCOLITIS AND OTHER GASTROINTESTINAL DISORDERS | UNIV JOHNS HOPKINS (US) | 2024-12-11 | — | — | EP | claimed |
| WO-2024249920-A2 | LIPID-GOLD SALT MOLECULES AND FORMULATION IN LIPID NANOPARTICLE DELIVERY SYSTEMS | NORTHWESTERN UNIVERSITY (US) | 2024-12-05 | — | — | WO | claimed |
| CN-118649243-B | Preparation and application of nucleic acid framework nano-drug for inducing copper death and blocking PD-L1 | 南方医科大学珠江医院 | 2024-11-08 | — | — | CN | claimed |
| CN-118649243-A | Preparation and application of nucleic acid framework nano-drug for inducing copper death and blocking PD-L1 | 南方医科大学珠江医院 | 2024-09-17 | — | — | CN | claimed |
| CN-118515857-A | Preparation method and application of sulfhydryl-containing sulfonated chitosan and poly (3, 4-ethylenedioxythiophene) complex | 河南师范大学 | 2024-08-20 | — | — | CN | claimed |
| US-20240216531-A1 | CHITOSAN-CONTAINING NANOPARTICLES FOR DELIVERY OF POLYNUCLEOTIDES | VALORISATION RECH HSCM LIMITED PARTNERSHIP (CA) | 2024-07-04 | — | — | US | claimed |
| CN-118184679-A | Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material | 中国石油天然气股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| US-4981953-A | ANTITUMOR | SANOFI (FR) | 1991-01-01 | — | — | US | claimed |
| EP-0234151-B1 | GLYCOPROTEINS MODIFIED BY OXIDATION AND FORMATION OF SCHIFF BASES, INHIBITING RIBOSOMES, PROCESS FOR OBTAINING THE SAME, AND IMMUNOTOXINES CONTAINING SUCH GLYCOPROTEIN | SANOFI (FR) | 1990-12-12 | — | — | EP | claimed |
| EP-0229564-B1 | GLYCOPROTEINS MODIFIED BY OXIDATION FOLLOWED BY REDUCTION, WHICH INHIBIT RIBOSOMES, PRODUCTION PROCESS AND IMMUNOTOXINES CONTAINING SUCH A GLYCOPROTEIN | SANOFI S.A. (FR) | 1990-09-26 | — | — | EP | claimed |
| EP-0146050-B1 | SITE SELECTIVE PLASMINOGEN ACTIVATOR AND METHOD OF MAKING AND USING SAME | Callewaert, Denis M. (US) | 1990-07-04 | — | — | EP | claimed |
| US-4911912-A | Treatment of glycoprotein with periodate and cyanoborohydride | SANOFI (FR) | 1990-03-27 | — | — | US | claimed |
| US-4911911-A | Treatment of glycoprotein with periodate in presence of amine | SANOFI (FR) | 1990-03-27 | — | — | US | claimed |
| EP-0305409-A1 | SOLUBILIZATION OF PROTEINS FOR PHARMACEUTICAL COMPOSITIONS USING POLYPROLINE CONJUGATION. | CETUS CORP (US) | 1989-03-08 | — | — | EP | claimed |
| WO-1988003412-A1 | SOLUBILIZATION OF PROTEINS FOR PHARMACEUTICAL COMPOSITIONS USING POLYPROLINE CONJUGATION | CETUS CORPORATION (US) | 1988-05-19 | — | — | WO | claimed |
| EP-0099395-B1 | SILANIZATION OF SURFACES | FÖRSVARETS FORSKNINGSANSTALT (SE) | 1986-09-10 | — | — | EP | claimed |
| US-4608246-A | Testing for a blood group immunological reaction | IMMUCOR, INC. (US) | 1986-08-26 | — | — | US | claimed |